Search

everythinglearnresearchcommunity

for

Search:↓

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Nanotechnology could make hair loss treatments more effective and reduce side effects, but more research is needed before it's available.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

The regenerative solution, tSVF, is a safe and effective treatment for various conditions like aged skin, scars, wounds, and more, but more research is needed to find the best way to use it.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Consider benefits and risks of new alopecia treatments for safety.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

New psoriasis treatments are effective but come with side effects and risks.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Combining cosmetic procedures with lifestyle changes improves antiaging results.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

A specific microRNA, chi-miR-30b-5p, slows down the growth of hair-related cells by affecting the CaMKIIδ gene in cashmere goats.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

The PP2A-B55α protein is essential for brain and skin development in embryos.